Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 755 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Retifanlimab Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over Standard Therapy in Patients with HR-positive, HER2-positive MBC FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma MOST POPULAR ΚΑΡΚΙΝΟΣ ΤΟΥ ΠΕΟΥΣ February 10, 2019 Advanced MRI could help to differentiate aggressive and slower growing prostate... February 14, 2022 Firefighters Band Together To Raise $30k For Breast Cancer Research &... September 24, 2021 April is Occupational Therapy (OT) Month- What is OT and how... April 8, 2021 Load more HOT NEWS Combo of Ribociclib, Letrozole Improves Survival in Advanced Breast Cancer Stage IV Cancer Patient Clinging to Life Overseas While Family Raises... Using Technology to Find Cancers Early and Exercise Improves Sexual Health... Darolutamide Extends Survival for Some People with Metastatic Prostate Cancer
